Vaxxinity appoints dr. peter powchik to board of directors

Dallas, march 21, 2022 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx), a u.s. company pioneering the development of a new class of immunotherapeutic vaccines for chronic diseases, today announced that peter powchik, m.d. is joining its board of directors and will be retiring as vaxxinity's executive vice president, research & development. this transition will be effective march 31, 2022 and will increase the size of the board to seven.
VAXX Ratings Summary
VAXX Quant Ranking